Trials / Completed
CompletedNCT01354340
Dose Effect of Limicol on (LDL)-Cholesterol Levels
Dose Effect of Limicol on (LDL)-Cholesterol Levels in Moderate Hypercholesterolaemia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (actual)
- Sponsor
- Lescuyer Laboratory · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The principal objective of this study is to investigate the dose-effect of the Limicol food supplement on LDL-cholesterol level in moderate hypercholesterolaemia subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Limicol | 3 tablets (Limicol) + 3 tablets (Placebo) / day during 1 month and follow-up 1 month without treatment |
| DIETARY_SUPPLEMENT | Limicol | 6 tablets (Limicol) / day during 1 month and follow-up 1 month without treatment |
| OTHER | Placebo | 6 tablets (Placebo) / day during 1 month and follow-up 1 month without treatment |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-12-01
- Completion
- 2012-01-01
- First posted
- 2011-05-16
- Last updated
- 2012-04-19
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01354340. Inclusion in this directory is not an endorsement.